BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 14661179)

  • 1. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
    Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
    Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
    Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
    Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked enhancement in gene expression by targeting the human insulin receptor.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Feb; 5(2):157-63. PubMed ID: 12539153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-specific expression of an exogenous gene after i.v. administration.
    Shi N; Zhang Y; Zhu C; Boado RJ; Pardridge WM
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12754-9. PubMed ID: 11592987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Trojan horse liposomes (THLs) for gene transfer across the blood-brain barrier.
    Pardridge WM
    Cold Spring Harb Protoc; 2010 Apr; 2010(4):pdb.prot5407. PubMed ID: 20360361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous, non-viral RNAi gene therapy of brain cancer.
    Pardridge WM
    Expert Opin Biol Ther; 2004 Jul; 4(7):1103-13. PubMed ID: 15268677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive gene targeting to the brain.
    Shi N; Pardridge WM
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7567-72. PubMed ID: 10840060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy.
    Chen X; Li Y; Xiong K; Xie Y; Aizicovici S; Snodgrass R; Wagner TE; Platika D
    Cancer Gene Ther; 1995 Dec; 2(4):281-9. PubMed ID: 8548582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.
    Zhang Y; Calon F; Zhu C; Boado RJ; Pardridge WM
    Hum Gene Ther; 2003 Jan; 14(1):1-12. PubMed ID: 12573054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread expression of an exogenous gene in the eye after intravenous administration.
    Zhu C; Zhang Y; Pardridge WM
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3075-80. PubMed ID: 12202532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ-specific expression of the lacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice.
    Zhu C; Zhang Y; Zhang YF; Yi Li J; Boado RJ; Pardridge WM
    J Gene Med; 2004 Aug; 6(8):906-12. PubMed ID: 15293349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
    Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell].
    Ma JP; Zhan WH; Wang JP; Peng JS; Gao JS; Yin QW
    Zhonghua Wai Ke Za Zhi; 2004 Nov; 42(22):1372-6. PubMed ID: 15634407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
    Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated delivery of an antisense gene to human brain cancer cells.
    Zhang Y; Jeong Lee H; Boado RJ; Pardridge WM
    J Gene Med; 2002; 4(2):183-94. PubMed ID: 11933219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
    Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
    Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.